This October, we saw two significant psychedelic studies being published that were previously released as pre-prints. The first is concerned with the extended DMT trial (also see Blossom’s April Recap), and the second investigates the antidepressant effects of ketamine when given to patients under anaesthesia (also see Blossom’s May Recap). Next to these studies, a good mix of surveys highlights…
